Her2 activation mechanism reflects evolutionary preservation of asymmetric ectodomain dimers in the human EGFR family

eLife

Volumn 2013, Issue 2, 2013, Pages

  Arkhipov, Anton ^a   Shan, Yibing ^a   Kim, Eric T ^a   Dror, Ron O ^a   Shaw, David E ^a,b  

^a D E SHAW RESEARCH   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR; ERBB2 PROTEIN, HUMAN;

ARTICLE; DIMERIZATION; HUMAN; MOLECULAR EVOLUTION; MUTATION; NONHUMAN; AMINO ACID SEQUENCE; CHEMISTRY; METABOLISM; MOLECULAR GENETICS; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; DIMERIZATION; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84880633751     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.00708     Document Type: Article

References (45)

1. Alvarado D, Klein DE, Lemmon MA. 2009. ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor. Nature 461:287-91. doi: 10.1038/nature08297.
2. Alvarado D, Klein DE, Lemmon MA. 2010. Structural basis for negative cooperativity in growth factor binding to an EGF receptor. Cell 142:568-79. doi: 10.1016/j.cell.2010.07.015.
3. Arkhipov A, Shan Y, Das R, Endres NF, Eastwood MP, Wemmer DE, et al. 2013. Architecture and membrane interactions of the EGF receptor. Cell 152:557-69. doi: 10.1016/j.cell.2012.12.030.
4. Baselga J, Swain SM. 2009. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat Rev Cancer 9:463-75. doi: 10.1038/nrc2656.
5. Berendsen HJC, Postma JPM, van Gunsteren WF, DiNola A, Haak JR. 1984. Molecular dynamics with coupling to an external bath. J Chem Phys 81:3684-90. doi: 10.1063/1.448118.
6. Bostrom J, Yu SF, Kan D, Appleton BA, Lee CV, Billeci K, et al. 2009. Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site. Science 323:1610-4. doi: 10.1126/ science.1165480.
7. Cho H-S, Leahy DJ. 2002. Structure of the extracellular region of HER3 reveals an interdomain tether. Science 297:1330-3. doi: 10.1126/science.1074611.
8. Cho H-S, Mason K, Ramyar KX, Stanley AM, Gabelli SB, Denney DW, et al. 2003. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 421:756-60. doi: 10.1038/nature01392.
9. Chung I, Akita R, Vandlen R, Toomre D, Schlessinger J, Mellman I. 2010. Spatial control of EGF receptor activation by reversible dimerization on living cells. Nature 464:783-7. doi: 10.1038/nature08827.
10. Citri A, Skaria KB, Yarden Y. 2003. The deaf and the dumb: the biology of ErbB-2 and ErbB-3. Exp Cell Res 284:54-65. doi: 10.1016/S0014-4827(02)00101-5.
11. Citri A, Yarden Y. 2006. EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 7:505-16. doi: 10.1038/nrm1962.
12. Dawson JP, Berger MB, Lin CC, Schlessinger J, Lemmon MA, Ferguson KM. 2005. Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface. Mol Cell Biol 25:7734-42. doi: 10.1128/MCB.25.17.7734-7742.2005.
13. Endres NF, Das R, Smith A, Arkhipov A, Kovacs E, Huang Y, et al. 2013. Conformational coupling across the plasma membrane in activation of the EGF receptor. Cell 152:543-56. doi: 10.1016/j.cell.2012.12.032.
14. Endres NF, Engel K, Das R, Kovacs E, Kuriyan J. 2011. Regulation of the catalytic activity of the EGF receptor. Curr Opin Struct Biol 27:777-84. doi: 10.1016/j.sbi.2011.07.007.
15. Ferguson KM, Berger MB, Mendrola JM, Cho HS, Leahy DJ, Lemmon MA. 2003. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Mol Cell 11:507-17. doi: 10.1016/ S1097-2765(03)00047-9.
16. Ferguson KM, Darling PJ, Mohan MJ, Macatee TL, Lemmon MA. 2000. Extracellular domains drive homo- but not hetero-dimerization of erbB receptors. EMBO J 19:4632-43. doi: 10.1093/emboj/19.17.4632.
17. Franklin MC, Carey KD, Vajdos FF, Leahy DJ, de Vos AM, Sliwkowski MX. 2004. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex. Cancer Cell 5:317-28. doi: 10.1016/S1535- 6108(04)00083-2.
18. Garrett TP, McKern NM, Lou M, Elleman TC, Adams TE, Lovrecz GO, et al. 2002. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor α. Cell 110:763-73. doi: 10.1016/S0092-8674(02)00940-6.
19. Garrett TPJ, McKern NM, Lou MZ, Elleman TC, Adams TE, Lovrecz GO, et al. 2003. The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. Mol Cell 11:495-05. doi: 10.1016/S0092-8674(02)00940-6.
20. Graus-Porta D, Beerli RR, Daly JM, Hynes NE. 1997. ErbB-2, the preferred heterodimerization partner of all erbb receptors, is a mediator of lateral signaling. EMBO J 16:1647-55. doi: 10.1093/emboj/16.7.1647.
21. Horan T, Wen J, Arakawa T, Liu N, Brankow D, Hu S, et al. 1995. Binding of Neu differentiation factor with the extracellular domain of Her2 and Her3. J Biol Chem 270:24604-8. doi: 10.1074/jbc.270.41.24604.
22. Humphrey W, Dalke A, Schulten K. 1996. VMD: visual molecular dynamics. J Mol Graph 14:33-8. doi: 10.1016/ 0263-7855(96)00018-5.
23. Hynes NE, Lane HA. 2005. Erbb receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 5:341-54. doi: 10.1038/nrc1667.
24. Jacobsen NE, Abadi N, Sliwkowski MX, Reilly D, Skelton NJ, Fairbrother WJ. 1996. High-resolution solution structure of the EGF-like domain of heregulin-α. Biochemistry 35:3402-17. doi: 10.1021/bi952626l.
25. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. 1983. Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926-35. doi: 10.1021/bi952626l.
26. Kräutler V, van Gunsteren WF, Hünenberger PH. 2001. A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations. J Comput Chem 22:501-8. doi: 10.1002/ 1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V.
27. Lemmon MA. 2009. Ligand-induced ErbB receptor dimerization. Exp Cell Res 315:638-48. doi: 10.1016/j. yexcr.2008.10.024.
28. Lemmon MA, Schlessinger J. 2010. Cell signaling by receptor tyrosine kinases. Cell 141:1117-34. doi: 10.1016/j. cell.2010.06.011.
29. Li S, Schmitz KR, Jeffrey PD, Wiltzius JJW, Kussie P, Ferguson KM. 2005. Structural basis for inhibition of the epidermal growth factor receptor by cetuximab. Cancer Cell 7:301-11. doi: 10.1016/j.ccr.2005.03.003.
30. Liu P, Cleveland TE IV, Bouyain S, Byrne PO, Longo PA, Leahy DJ. 2012. A single ligand is sufficient to activate EGFR dimers. Proc Natl Acad Sci USA 109:10861-6. doi: 10.1073/pnas.1201114109.
31. Lu CF, Mi LZ, Grey MJ, Zhu JQ, Graef E, Yokoyama S, et al. 2010. Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor. Mol Cell Biol 30:5432-43. doi: 10.1128/MCB.00742-10.
32. MacKerell AD, Bashford D, Bellott M, Dunbrack RL, Evanseck JD, Field MJ, et al. 1998. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 102:3586-616. doi: 10.1021/jp973084f.
33. Nagy P, Claus J, Jovin TM, Arndt-Jovin DJ. 2010. Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis. Proc Natl Acad Sci USA 107:16524-9. doi: 10.1073/pnas.1002642107.
34. Ogiso H, Ishitani R, Nureki O, Fukai S, Yamanaka M, Kim JH, et al. 2002. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110:775-87. doi: 10.1016/ S0092-8674(02)00963-7.
35. Piana S, Lindorf-Larsen K, Shaw DE. 2011. How robust are protein folding simulations with respect to force field parameterization? Biophys J 100:L47-9. doi: 10.1016/j.bpj.2011.03.051.
36. Riese DJ II, Gallo RM, Settleman J. 2007. Mutational activation of ErbB family receptor tyrosine kinases: insights into mechanisms of signal transduction and tumorigenesis. Bioessays 29:558-65. doi: 10.1002/bies.20582.
37. Schreiber AB, Libermann TA, Lax I, Yarden Y, Schlessinger J. 1983. Biological role of epidermal growth factor-receptor clustering. Investigation with monoclonal anti-receptor antibodies. J Biol Chem 258:846-53.
38. Shan Y, Klepeis JL, Eastwood MP, Dror RO, Shaw DE. 2005. Gaussian split Ewald: a fast Ewald mesh method for molecular simulation. J Chem Phys 122:54101-13. doi: 10.1063/1.1839571.
39. Shaw DE, Dror RO, Salmon JK, Grossman JP, Mackenzie KM, Bank JA, et al. 2009. Millisecond-scale molecular dynamics simulations on Anton. In Proceedings of the conference on high performance computing networking, storage and analysis, Portland, Oregon, ACM. p. 1-11. doi: 10.1145/1654059.1654099.
40. Stein RA, Staros JV. 2000. Evolutionary analysis of the ErbB receptor and ligand families. J Mol Evol 50:397-412. doi: 10.1007/s002390010043.
41. Tuckerman M, Berne BJ, Martyna GJ. 1992. Reversible multiple time scale molecular dynamics. J Chem Phys 97:1990-2001. doi: 10.1063/1.463137.
42. Tynan CJ, Roberts SK, Rolfe DJ, Clarke DT, Loeffler HH, Kastner J, et al. 2011. Human epidermal growth factor receptor (EGFR) aligned on the plasma membrane adopts key features of Drosophila EGFR asymmetry. Mol Cell Biol 31:2241-52. doi: 10.1128/MCB.01431-10.
43. Ushiro H, Cohen S. 1980. Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes. J Biol Chem 255:8363-5.
44. Zhang X, Gureasko J, Shen K, Cole PA, Kuriyan J. 2006. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125:1137-49. doi: 10.1016/j.cell.2006.05.013.
45. Zhang Z, Wriggers W. 2011. Polymorphism of the epidermal growth factor receptor extracellular ligand binding domain: the dimer interface depends on domain stabilization. Biochemistry 50:2144-56. doi: 10.1021/bi101843s.